Baird Medical Investment Holdings (BDMD) Receivables (2023 - 2025)

Baird Medical Investment Holdings has reported Receivables over the past 3 years, most recently at $47.6 million for Q4 2025.

  • For Q4 2025, Receivables rose 1.42% year-over-year to $47.6 million; the TTM value through Dec 2025 reached $47.6 million, up 1.42%, while the annual FY2025 figure was $47.6 million, 2.16% up from the prior year.
  • Receivables for Q4 2025 was $47.6 million at Baird Medical Investment Holdings, up from $6.6 million in the prior quarter.
  • Over five years, Receivables peaked at $47.6 million in Q4 2025 and troughed at -$4.1 million in Q2 2024.
  • A 3-year average of $25.7 million and a median of $31.5 million in 2023 define the central range for Receivables.
  • On a YoY basis, Receivables climbed as much as 258.42% in 2025 and fell as far as 1.42% in 2025.
  • Year by year, Receivables stood at $31.5 million in 2023, then soared by 48.97% to $46.9 million in 2024, then rose by 1.42% to $47.6 million in 2025.
  • Business Quant data shows Receivables for BDMD at $47.6 million in Q4 2025, $6.6 million in Q2 2025, and $46.9 million in Q4 2024.